A phase 2 study of Vigil Neuroscience’s iluzanebart has missed its biomarker and efficacy endpoints, prompting the ...

The highly anticipated presentation will be delivered by Francisco Silva, Vice President of Research and Development at ...

SRM Institute of Science and Technology has released the SRMJEEE 2025 phase two schedule. Online registration concludes on ...

The trial is expected to generate significant clinical data by late summer 2026. Allarity plans to pursue multiple advantaged ...

Corcept Therapeutics has tried to cast its recent phase 2 amyotrophic lateral sclerosis (ALS) failure in a more flattering ...

The Knoxville Community Development Corporation broke ground on Phase 2 of the Transforming Western initiative Wednesday.

Larimer County Commissioners gave staff at the Ranch Events Complex the go-ahead to begin work on the second phase of the ...

Explore how the Air Force Safety Center's phase two of the Integrating Risk and Readiness campaign could empower airmen.

The FDA cleared an investigational new drug application for a phase 2 trial of GRF312 ophthalmic solution, an immunoglobulin eye drop for the treatment of dry eye disease, according to a press release ...

Shares of Sun Pharma Advanced Research Company Ltd (SPARC) plunged nearly 20% on Wednesday on the NSE, after the company ...

The topic of mitigating cachexia is a highly topical one. This randomized phase II study, albeit negative for primary end point, provides some insights for the field and an avenue for further ...